Ajax-Loading

Eli Lilly and Company - Return On Assets

Eli Lilly and Company's Fiscal Year is From January To December - All Figures are in Percent.

The item "Return-On-Assets" stands at 19.18 percent as of 09/30/2025, the highest value at least since 06/30/2022, the period currently displayed.

As of the end of Eli Lilly and Company's third quarter, the item "Return On Assets" stands at 19.18 Percent. This represents an increase of 3.16 percentage points compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 7.03 percentage points compared to the value the year prior.
The 1 year change in percentage points is 7.03.
The 3 year change in percentage points is 6.50.

The Serie's long term average value is 12.71 percent. It's latest available value, on 09/30/2025, is 6.47 percentage points higher, compared to it's long term average value.
The Serie's change in percentage points from it's minimum value, on 12/31/2023, to it's latest available value, on 09/30/2025, is +10.06.
The Serie's change in percentage points from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0.

Return On Assets for Related Companies:

LogoNameMarket Cap (USD)
LogoJohnson & Johnson - Return On Assets486,508,953,600.00
LogoAbbVie Inc - Return On Assets399,570,305,024.00
LogoRoche Holding AG - Return On Assets317,433,206,677.55
LogoAstraZeneca PLC - Return On Assets280,205,508,085.11
LogoNovartis AG - Return On Assets255,096,620,580.91